Complete Story


Priority Health Update

Priority Health Managed Care Committee Member

Flora Varga

Flora Varga, Cancer & Hematology Centers of West Michigan

Retacrit supply shortage expected soon

Pfizer informed Priority Health that Retacrit will experience a supply disruption beginning in late May 2022, with a targeted return to supply in early Q4 2022.  To see the list of covered alternatives READ MORE

Some Site of Service Restrictions Started April 1st!

Infliximab -The prior authorization requirement for Infliximab products was removed in May 2020 to remove administrative burden. Beginning April 1st, prior authorization is required for the continued administration of infliximab products at a non-preferred site of care. However, if a preferred site of care is utilized, according to the members plan, no authorization will be required.

To review other infusion therapies with site of service restrictions, CLICK HERE


Printer-Friendly Version

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it! 
Report Broken Link